Arkolith/Insider Trading/FWBI/Form 4

Sapirstein James

Chairman, President and CEO, DirectorFirst Wave BioPharma, Inc. (FWBI) · full profile →Form 4 · filed Jan 17, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$697
Net Open-Market Flow
-$697
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 12, 2024Sell(S)166$4.20$69739K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-004458) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML